 | • レポートコード：MRC2302F0020 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、253ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に6,359.36百万ドルであった世界の経皮パッチ市場規模が、2022年に7,380.04百万ドルになり、2027年には15,676.78百万ドルまで、年平均16.22%で成長すると予測しています。本レポートでは、経皮パッチの世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（マトリックス、多層薬剤含有接着剤、単層薬剤含有接着剤）分析、技術別（化学増強剤、電流、機械的アレイ、熱アブレーション）分析、用途別（ホルモン療法、過活動膀胱、鎮痛、禁煙・減煙支援）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でお届けします。なお、本書には、3M Company、Abbott Laboratories, Limited、Acrux Limited、AdhexPharma、ANI Pharmaceuticals Inc.、Bayer AG、Henan Lingrui Pharmaceutical Ltd、Hisamitsu Pharmaceutical Co., Inc.、Johnson & Johnson、Luye Pharma Group、Medherant Limited、Mylan NV (Viatris)、Nitto Denko Corporation、Novartis AG、Purdue Pharma Manufacturing LP、Samyang Biopharmaceuticals Corp.、Tapemark Company、Teikoku Pharma USA Inc.、Tesa Labtec GmbH、Teva Pharmaceutical Industries Ltd.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の経皮パッチ市場規模：種類別 - マトリックスの市場規模 - 多層薬剤含有接着剤の市場規模 - 単層薬剤含有接着剤の市場規模 ・世界の経皮パッチ市場規模：技術別 - 化学増強剤における市場規模 - 電流における市場規模 - 機械的アレイにおける市場規模 - 熱アブレーションにおける市場規模 ・世界の経皮パッチ市場規模：用途別 - ホルモン療法における市場規模 - 過活動膀胱における市場規模 - 鎮痛における市場規模 - 禁煙・減煙支援における市場規模 ・世界の経皮パッチ市場規模：地域別 - 南北アメリカの経皮パッチ市場規模 アメリカの経皮パッチ市場規模 カナダの経皮パッチ市場規模 ブラジルの経皮パッチ市場規模 ... - アジア太平洋の経皮パッチ市場規模 日本の経皮パッチ市場規模 中国の経皮パッチ市場規模 インドの経皮パッチ市場規模 韓国の経皮パッチ市場規模 台湾の経皮パッチ市場規模 ... - ヨーロッパ/中東/アフリカの経皮パッチ市場規模 イギリスの経皮パッチ市場規模 ドイツの経皮パッチ市場規模 インドの経皮パッチ市場規模 フランスの経皮パッチ市場規模 ロシアの経皮パッチ市場規模 ... - その他地域の経皮パッチ市場規模 ・競争状況 ・企業情報 |
The Global Transdermal Skin Patches Market size was estimated at USD 6,359.36 million in 2021 and expected to reach USD 7,380.04 million in 2022, and is projected to grow at a CAGR 16.22% to reach USD 15,676.78 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Transdermal Skin Patches to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Matrix, Multi-layer Drug-in-Adhesive, and Single-layer Drug-in-Adhesive.
Based on Technology, the market was studied across Chemical Enhancers, Electric current, Mechanical arrays, and Thermal Ablation.
Based on Application, the market was studied across Hormonal Therapy, Overactive Bladder, Pain Relief, and Smoking Reduction and Cessation Aid.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Transdermal Skin Patches market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transdermal Skin Patches Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Transdermal Skin Patches Market, including 3M Company, Abbott Laboratories, Limited, Acrux Limited, AdhexPharma, ANI Pharmaceuticals Inc., Bayer AG, Henan Lingrui Pharmaceutical Ltd, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Luye Pharma Group, Medherant Limited, Mylan NV (Viatris), Nitto Denko Corporation, Novartis AG, Purdue Pharma Manufacturing LP, Samyang Biopharmaceuticals Corp., Tapemark Company, Teikoku Pharma USA Inc., Tesa Labtec GmbH, and Teva Pharmaceutical Industries Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Transdermal Skin Patches Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transdermal Skin Patches Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transdermal Skin Patches Market?
4. What is the competitive strategic window for opportunities in the Global Transdermal Skin Patches Market?
5. What are the technology trends and regulatory frameworks in the Global Transdermal Skin Patches Market?
6. What is the market share of the leading vendors in the Global Transdermal Skin Patches Market?
7. What modes and strategic moves are considered suitable for entering the Global Transdermal Skin Patches Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased use in the treatment of migraine, cardiovascular diseases, and neurology disease
5.1.1.2. Demand for a controlled drug release system to the patient
5.1.1.3. Increasing number of smokers with rising initiatives to spread awareness about health impacts of smoking
5.1.2. Restraints
5.1.2.1. Limitation of active substances that are absorbed through skin
5.1.2.2. Inappropriate for high drug doses
5.1.3. Opportunities
5.1.3.1. Growing funding and investments for drug development
5.1.3.2. Government initiatives and increase in the number of partnerships
5.1.4. Challenges
5.1.4.1. Varying adhesion with patch type and environmental conditions
5.2. Cumulative Impact of COVID-19
6. Transdermal Skin Patches Market, by Type
6.1. Introduction
6.2. Matrix
6.3. Multi-layer Drug-in-Adhesive
6.4. Single-layer Drug-in-Adhesive
7. Transdermal Skin Patches Market, by Technology
7.1. Introduction
7.2. Chemical Enhancers
7.3. Electric current
7.4. Mechanical arrays
7.5. Thermal Ablation
8. Transdermal Skin Patches Market, by Application
8.1. Introduction
8.2. Hormonal Therapy
8.3. Overactive Bladder
8.4. Pain Relief
8.5. Smoking Reduction and Cessation Aid
9. Americas Transdermal Skin Patches Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Transdermal Skin Patches Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Transdermal Skin Patches Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3M Company
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Abbott Laboratories, Limited
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Acrux Limited
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. AdhexPharma
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. ANI Pharmaceuticals Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Bayer AG
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Henan Lingrui Pharmaceutical Ltd
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Hisamitsu Pharmaceutical Co., Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Johnson & Johnson
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Luye Pharma Group
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Medherant Limited
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Mylan NV (Viatris)
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Nitto Denko Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Novartis AG
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Purdue Pharma Manufacturing LP
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Samyang Biopharmaceuticals Corp.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Tapemark Company
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Teikoku Pharma USA Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Tesa Labtec GmbH
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Teva Pharmaceutical Industries Ltd.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing